医学
溶栓
血管内治疗
二级预防
缺血性中风
急性中风
闭塞
冲程(发动机)
心脏病学
放射科
外科
内科学
缺血
组织纤溶酶原激活剂
心肌梗塞
动脉瘤
工程类
机械工程
作者
Mayank Goyal,Manon Kappelhof,Rosalie McDonough,Johanna M. Ospel
出处
期刊:Stroke
[Ovid Technologies (Wolters Kluwer)]
日期:2021-01-20
卷期号:52 (3): 1147-1153
被引量:16
标识
DOI:10.1161/strokeaha.120.032799
摘要
Medium vessel occlusions (MeVOs, ie, M2, M3, A2, A3, P2, and P3 segment occlusions) are increasingly recognized as a target for endovascular treatment in acute ischemic stroke. It is important to note that not all MeVOs are equal. Primary MeVOs occur de novo with the underlying mechanisms being very similar to large vessel occlusion strokes. Secondary MeVOs arise from large vessel occlusions through clot migration or fragmentation, either spontaneously or following treatment with intravenous thrombolysis or endovascular treatment. Currently, there are little data on the prevalence, management, and prognosis of acute ischemic stroke due to secondary MeVOs. This type of stroke is, however, likely to become more relevant in the future as indications for endovascular treatment continue to broaden. In this article, we describe different types of secondary MeVOs, imaging findings associated with them, challenges related to the diagnosis of secondary MeVOs, and their potential implications for treatment strategies and clinical outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI